“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.” A great deal… Read More »
The patient is a man in his 30s who got the shot on April 27 because of his job at a medical facility, Korea Disease Control and Prevention Agency (KDCA) director Jeong Eun-kyeong told a briefing. He felt a headache on May 9 and sought medical treatment before being hospitalised on May 12 as it… Read More »
Its COVID-19 vaccine has been vilified and its manufacturing network has been questioned, but AstraZeneca is still planning to apply for emergency use authorization of its shot in the U.S., a company spokesman confirmed. A month ago, after AZ said its vaccine succeeded in phase 3 testing, an AstraZeneca executive said the company would apply for an emergency… Read More »
The Coronavirus Outbreak liveLatest Updates Maps and Cases Risk Near You Who Can Get Vaccinated? Vaccine Questions Advertisement Continue reading the main story Supported by Continue reading the main story AstraZeneca Vaccine and Blood Clots: What Is Known So Far In rare cases, an immune reaction has led to antibodies that caused a serious clotting… Read More »
The blood clot controversy surrounding AstraZeneca’s COVID-19 vaccine seemed to be subsiding on the continent but now that looks to change. Germany has decided to bar people under the age of 60 from getting the jab following reports of rare blood clots in the brains of 31 people who received the first dose of the… Read More »
A coronavirus vaccine developed by AstraZeneca and the University of Oxford was strongly protective against COVID-19 in the partners’ largest study yet, a significant finding for a shot that has been mired in controversy but could still play a crucial role. The result, which comes from a Phase 3 trial of 32,449 participants in the… Read More »